首页> 美国卫生研究院文献>other >Poppers and PrEP: Use of Pre-Exposure Prophylaxis among Men Who HaveSex with Men Who Use Inhaled Nitrites
【2h】

Poppers and PrEP: Use of Pre-Exposure Prophylaxis among Men Who HaveSex with Men Who Use Inhaled Nitrites

机译:Poppers和PrEP:在患有以下疾病的男性中使用暴露前预防措施与使用吸入亚硝酸盐的男人做爱

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Men who have sex with men (MSM) commonly use inhaled nitrites, or poppers, though their use is a risk factor HIV seroconversion. Pre-exposure prophylaxis, or PrEP, is effective for HIV prevention, but is not widely used, and little is known regarding PrEP use and acceptability among MSM who use inhaled nitrites. We surveyed 580 MSM in Paris, France in 2016 about popper use, sexual behaviors including condomless anal intercourse (CAI), serosorting, and sexual positioning, PrEP use, PrEP candidacy, and interest in alternate PrEP delivery modalities. We included 444 HIV negative participants for the current study. 46.2% reported popper use in the prior 3 months. Using multivariate adjusted logistic regression, we found that popper users were more likely than non-users to consider themselves candidates for PrEP (adjusted relative risk ratio (aRRR)=2.73; 95% CI=1.54–4.83), but they were not more likely to be current (aRRR=1.54; 95% CI=0.71–3.33) or past (aRRR=1.37; 95% CI=0.44–4.28) PrEP users. Mediation analyses indicated that increased CAI and serosorting partly explained the relationship between popper use and PrEP candidacy. There was considerableinterest in alternate proposed PrEP delivery modalities, particularlylong-acting injectable PrEP (adjusted risk ratio (aRR)=1.43; 95%CI=1.15–1.79).
机译:与男性发生性行为(MSM)的男性通常使用吸入的亚硝酸盐或波普尔,尽管使用是艾滋病毒血清转化的危险因素。暴露前预防或PrEP对HIV预防有效,但并未广泛使用,并且对于使用吸入亚硝酸盐的MSM中PrEP的使用和可接受性知之甚少。我们在2016年对法国巴黎的580名男男性接触者进行了调查,调查涉及使用波普尔,包括无避孕套肛门性交(CAI),血清分拣和性定位在内的性行为,使用PrEP,PrEP候选资格以及对其他PrEP传递方式的兴趣。在本研究中,我们纳入了444名HIV阴性参与者。 46.2%的人报告前三个月使用了波普尔。使用多元调整的对数回归,我们发现,与非使用者相比,popper使用者更有可能认为自己是PrEP的候选人(经修正的相对风险比(aRRR)= 2.73; 95%CI = 1.54–4.83),但他们的可能性不大是当前(aRRR = 1.54; 95%CI = 0.71–3.33)或过去(aRRR = 1.37; 95%CI = 0.44–4.28)PrEP用户。调解分析表明,CAI和血清分选的增加部分解释了波普尔使用与PrEP候选资格之间的关系。有很多对其他提议的PrEP交付方式的兴趣,尤其是长效可注射PrEP(调整后的风险比(aRR)= 1.43; 95%CI = 1.15–1.79)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号